Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-09Clinical Trial Update: Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 study evaluating the effects of the amlodipine/benazepril combination on albuminuria in hypertensive patients with type 2 diabetes. …
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial [Phase 3]
This update notes the completion of a Phase 3 trial evaluating a fixed-dose combination pill of losartan potassium and hydrochlorothiazide t…
-
EMA withdrawal · 2011-03-02EMA Withdrawn: Thelin (sitaxentan sodium) — Pfizer Ltd.
Thelin (sitaxentan sodium) has been withdrawn from the market by Pfizer Ltd., with a status of Withdrawn in the EMA record.
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension [Phase 4]
A Phase 4 trial comparing aliskiren/HCTZ to ramipril in obese patients with stage 2 hypertension has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-28Clinical Trial Update: Olmesartan Comparison to Losartan in Hypertensive Subjects [Phase 4]
Phase 4 clinical trial comparing olmesartan to losartan in hypertensive subjects, with results posted in 2011.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-28Clinical Trial Update: PHARES Study: Management of Resistant Hypertension [Phase 4]
The PHARES Study, a Phase 4 trial evaluating management approaches for resistant hypertension, has completed.
-
FDA approval · 2011-02-25FDA Approved: EDARBI — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved EDARBI (azilsartan medoxomil) under the original NDA from Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension [Phase 3]
A Phase 3 clinical trial comparing an aliskiren-based regimen with a lisinopril-based regimen for severe hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Microvascular Dilatation After Endogenous Induced Hyperinsulinemia [NA]
Completed clinical trial investigating microvascular dilatation after endogenous induced hyperinsulinemia in participants with hypertension …
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension [NA]
A pilot study evaluated treatment for hypertension induced by VEGF signaling pathway inhibitors. The trial was terminated, and its results w…
-
FDA approval · 2011-02-14FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride (Dr. Reddy's) as a fixed-dose generic combi…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard
A completed clinical study assessing the performance of a blood pressure monitor in conformance with the ANSI/AAMI SP10 standard for hyperte…
-
FDA approval · 2011-02-11FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc., representing a supplemental approval for a generic prod…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Coreg CR, Blood Vessel Stiffness and Blood Vessel Function [Phase 4]
A Phase 4 clinical trial update for Coreg CR (carvedilol extended-release) evaluating blood vessel stiffness and endothelial function in pat…
-
CLINICAL_TRIALS trial_result · 2011-02-09Clinical Trial Update: Effect of Whey Protein on Blood Pressure [NA]
Completed clinical trial sponsored by the USDA evaluating whether whey protein affects blood pressure in people with hypertension.
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of valsartan plus amlodipine versus amlodipine alone for hypertension; results were posted …
-
FDA approval · 2011-02-07FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for CARDENE IV (nicardipine hydrochloride) from Baxter Healthcare Corporation, related to the IV for…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension [Phase 4]
Phase 4 trial comparing valsartan/amlodipine versus losartan in patients with stage 2 systolic hypertension; results posted in 2011.
-
CLINICAL_TRIALS research · 2011-02-04Clinical Trial Update: Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study to identify the optimal renoprotective dose of aliskiren in hypertensive patients wit…
-
FDA approval · 2011-02-03FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Lupin Pharmaceuticals, signaling an updated labe…
-
FDA approval · 2011-02-03FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for labetalol hydrochloride submitted by NorthStar Rx LLC under an ANDA. The approval confirms the r…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of aliskiren with hydrochlorothiazide (± amlodipine 5 mg) in patients with moderate hyper…
-
FDA approval · 2011-01-27FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for furosemide from Solco Healthcare LLC under an ANDA, authorizing a manufacturing or labeling chan…
-
FDA approval · 2011-01-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Diltiazem Hydrochloride from Teva Pharmaceuticals USA, Inc., updating the product's regulato…
-
FDA approval · 2011-01-27FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for furosemide from Ipca Laboratories Limited under an ANDA, signaling approval of changes to the ge…